Company intelligence / Profile preview

Agrivalle

Indaiatuba, São Paulo, Brazil

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Agrivalle develops and commercializes biological products including biocontrol agents, fertilizers, bio-stimulants, adjuvants, and inoculants. The company has filed 7 patents, with key focus areas including fungal plant pathogens and agricultural pest insects.

Therapeutic areas: OtherInfectious Diseases
Modalities: Microbial therapyLive biotherapeutic product therapyRecombinant protein
Industry: Agriculture & AgTech

Partnerships

Ginkgo Bioworks (multiyear strategic partnership announced December 2023 for strain optimization and next-generation biologicals development)

Beyond the preview

Go deeper on Agrivalle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agrivalle.

Explore the full profile